StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines accounts receivable, net ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, Q2 2026
1,056
Period ended Jun 30, 2026
Change on a year earlier
+37.0%
771 in Q2 2025
History
36 quarters
Since Q3 2017
Sources
36
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccounts receivable, net ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,056+37.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026938+30.8%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 2025865+27.9%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 2025863+51.7%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 2025771+45.6%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025717+64.8%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 2024676+88.9%Form 10-K (filed 2025-02-27) ↗
Q3 2024Sep 30, 2024569+84.1%Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 2024529+76.9%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024435+40.6%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 2023358+106.7%Form 10-K (filed 2024-02-26) ↗
Q3 2023Sep 30, 2023309+63.4%Form 10-Q (filed 2023-11-09) ↗
Q2 2023Jun 30, 2023299+73.7%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 2023310+62.3%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 2022173-64.1%Form 10-K (filed 2023-02-27) ↗
Q3 2022Sep 30, 2022189+46.0%Form 10-Q (filed 2022-11-09) ↗

Cite this data

StockData. (2026). BeOne Medicines Accounts receivable, net ($M) ($M), quarterly Q3 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_ar

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.